Stopping a GLP-1: What to Discuss Before Changing Treatment
What the labels and trials say about stopping semaglutide or tirzepatide, which situations call for contacting your clinician now, and a checklist for planning a pause or an end to treatment together.
On this page
The short answer
Do not stop a GLP-1 on your own; talk with your prescriber first, because the decision depends on your health, your goals, and your plan for what comes next. Two situations are set by the labels rather than preference: stop and contact your clinician promptly if pancreatitis is suspected, and discontinue when a pregnancy is recognized. In the randomized withdrawal trials described in the labels, people who switched to placebo regained on average part of the weight they had lost, so a plan for monitoring and support is worth making before any change.
When does stopping a GLP-1 need a call or care now?
Contact a clinician now, rather than waiting for a planning conversation, if you have severe, persistent abdominal pain that may spread to your back, with or without nausea or vomiting. Both labels list this as a possible sign of pancreatitis and tell patients to stop the medicine promptly and contact their healthcare provider if it is suspected. 3 4 Swelling of the face, lips, tongue, or throat, or trouble breathing, can signal a serious allergic reaction and needs emergency care. 3 4
If you become pregnant while on either medicine, call your doctor immediately. Both labels say to discontinue when pregnancy is recognized. 3 4 MedlinePlus likewise says to call your doctor immediately. 2 The Wegovy label also says to discontinue at least 2 months before a planned pregnancy because of semaglutide's long half-life, so tell your prescriber early if you are planning one. 3
These are the situations the labels name. They are not a complete list, and nothing here tells you your own symptoms are minor. For other side effects, see our GLP-1 side effects guide.
Should I stop a GLP-1 on my own?
No. MedlinePlus says to continue semaglutide injection even if you feel well and not to stop using it without talking to your doctor. 2 Stopping is a clinical decision with trade-offs, and your prescriber can weigh your health history, how the medicine has worked for you, and what you want next. This article cannot tell you whether to stop, and it does not give any dosing or tapering instructions. For those, use your own product's instructions and your prescriber.
What happens to weight after stopping?
NIDDK says you probably will regain some weight after you stop weight management medication, and that healthy eating habits and more physical activity may help you regain less or keep weight off. 1 The two labels each describe a trial built to test this:
| Wegovy (Study 5) | Zepbound (Study 4) | |
|---|---|---|
| Design | After a 20-week run-in on the medicine, people were randomized to continue it or switch to placebo for 48 weeks | After 36 weeks on the medicine, people were randomized to continue it or switch to placebo for 52 weeks |
| Switched to placebo | Average weight change of +6.9% from week 20 to week 68 | Average weight change of +14.0% from week 36 to week 88 |
| Continued medicine | Average weight change of -7.9% over the same period | Average weight change of -5.5% over the same period |
| Source | 3 | 4 |
Read these as averages from specific trial populations. The two trials differ in length and design, so do not compare the columns as a ranking of the medicines. They do not tell you what will happen to you. They support one planning point: if you stop, expect to need a plan for what follows.
How long might treatment continue?
NIDDK says that if you have lost enough weight to improve your health and are not having serious side effects, your clinician may advise staying on the medication indefinitely. It also says that if you have not lost at least 5% of your starting weight after 12 weeks on the full dose, your clinician will probably advise stopping, and may change the plan or consider a different medicine. 1 No universal timeline exists. Our guide to why weight loss on a GLP-1 may be slower than expected covers questions to raise if progress is not what you hoped.
What should I discuss with my clinician before stopping or pausing?
Bring this checklist to your appointment. Fill in only what applies.
| Topic | What to ask or say |
|---|---|
| Your reason | Is it side effects, cost, access, a planned pregnancy, a procedure, or a feeling that you no longer need it? Different reasons point to different options, including a different medicine or a pause. |
| The plan, not just the date | Who will you see after the change, how often, and what would prompt an earlier visit? |
| Monitoring | Which measures will you track (weight trend, appetite, blood pressure, blood glucose if you have diabetes) and who reviews them? |
| Conditions you manage | If you take other medicines for blood sugar or blood pressure, ask whether they need review as treatment changes. |
| Eating and movement | What routines will you keep or build, such as protein, strength training, and walking? See our care plan guide. |
| Restarting | If you need to resume later, how is that handled, and does the process change if you stop for a time? |
| Cost and supply | Is cost driving the decision? Ask about alternatives before deciding. Our cost guide lists the numbers worth asking for. |
| Planned pregnancy or surgery | Tell your clinician early; timing can matter for both. 3 4 |
If you are changing providers rather than stopping, use our care-handoff checklist so your records and supply move together.
Common questions
Is it okay to just run out of medicine?
Let your prescriber know before you run out, so the decision is made together and a follow-up is in place. If cost or access is the reason, say so; there may be options to discuss.
Can I change my mind and restart?
That is a decision for you and your prescriber, who will decide how to restart safely. Do not restart from leftover supply on your own.
What if I feel worse after stopping?
Contact your care team and describe what you notice and when it started. If you have severe abdominal pain or signs of an allergic reaction, get care now. For visit prep, see preparing for your follow-up appointment, and for the first months of care, our first 90 days planner.
References
- Prescription Medications to Treat Overweight & Obesity — National Institute of Diabetes and Digestive and Kidney Diseases
- Semaglutide Injection — MedlinePlus, U.S. National Library of Medicine
- Wegovy Prescribing Information — Novo Nordisk
- Zepbound Prescribing Information — Eli Lilly
For your information. This article provides general education and does not replace medical advice or an individual evaluation. Talk to your clinician before starting, changing, or stopping treatment. Compounded medications are not FDA-approved.